(Q36321778)

13 August 2017

1 reference

title

Technology Insight: an overview of research in drug-eluting stents (English)

1 reference

13 August 2017

2

Patrick W Serruys

1 reference

13 August 2017

Andrew T L Ong

1

1 reference

13 August 2017

publication date

1 December 2005

1 reference

Nature Clinical Practice Cardiovascular Medicine

13 August 2017

published in

1 reference

13 August 2017

volume

2

1 reference

13 August 2017

issue

12

1 reference

13 August 2017

page(s)

647-658

1 reference

Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

21 January 2018

Pimecrolimus: a review.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Pathology of in-stent restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Thrombosis modulates arterial drug distribution for drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Late angiographic stent thrombosis (LAST) events with drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

A paclitaxel-eluting stent for the prevention of coronary restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization: the TiNOX trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

First human experience with the 17-beta-estradiol-eluting stent: the Estrogen And Stents To Eliminate Restenosis (EASTER) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Study of antirestenosis with the BiodivYsio dexamethasone‐eluting stent (STRIDE): A first‐in‐human multicenter pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXi trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

Late coronary occlusion after intracoronary brachytherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

inferred from DOI database lookup

7 January 2021

based on heuristic

Late coronary stent thrombosis: early vs. late stent thrombosis in the stent era

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0378

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NCPCARDIO0378

1 reference

13 August 2017

1 reference